119 related articles for article (PubMed ID: 15611661)
1. TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importance.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Cell Cycle; 2005 Jan; 4(1):8-9. PubMed ID: 15611661
[TBL] [Abstract][Full Text] [Related]
2. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
[TBL] [Abstract][Full Text] [Related]
3. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
Tacconelli A; Farina AR; Cappabianca L; Desantis G; Tessitore A; Vetuschi A; Sferra R; Rucci N; Argenti B; Screpanti I; Gulino A; Mackay AR
Cancer Cell; 2004 Oct; 6(4):347-60. PubMed ID: 15488758
[TBL] [Abstract][Full Text] [Related]
4. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Pellegrini C; Fargnoli MC; Mackay AR
J Exp Clin Cancer Res; 2018 Jun; 37(1):119. PubMed ID: 29914559
[TBL] [Abstract][Full Text] [Related]
5. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
[TBL] [Abstract][Full Text] [Related]
6. The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
Cappabianca L; Zelli V; Pellegrini C; Sebastiano M; Maccarone R; Clementi M; Chiominto A; Ruggeri P; Cardelli L; Ruggieri M; Sbaffone M; Fargnoli MC; Guadagni S; Farina AR; Mackay AR
Cells; 2023 Jan; 12(2):. PubMed ID: 36672171
[TBL] [Abstract][Full Text] [Related]
7. TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.
Farina AR; Di Ianni N; Cappabianca L; Ruggeri P; Ragone M; Ianni G; Gulino A; Mackay AR
Biomed Res Int; 2013; 2013():740187. PubMed ID: 23841091
[TBL] [Abstract][Full Text] [Related]
8. The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.
Ruggeri P; Farina AR; Di Ianni N; Cappabianca L; Ragone M; Ianni G; Gulino A; Mackay AR
PLoS One; 2014; 9(4):e94568. PubMed ID: 24736663
[TBL] [Abstract][Full Text] [Related]
9. Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
Farina AR; Cappabianca L; Ruggeri P; Gneo L; Maccarone R; Mackay AR
Oncotarget; 2015 Nov; 6(34):35636-51. PubMed ID: 26415233
[TBL] [Abstract][Full Text] [Related]
10. The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Panella S; Chioda A; Romanelli A; Pedone C; Gulino A; Mackay AR
Mol Cell Biol; 2009 Sep; 29(17):4812-30. PubMed ID: 19564412
[TBL] [Abstract][Full Text] [Related]
11. TrkAIII expression in the thymus.
Tacconelli A; Farina AR; Cappabianca L; Cea G; Panella S; Chioda A; Gallo R; Cinque B; Sferra R; Vetuschi A; Campese AF; Screpanti I; Gulino A; Mackay AR
J Neuroimmunol; 2007 Feb; 183(1-2):151-61. PubMed ID: 17241672
[TBL] [Abstract][Full Text] [Related]
12. Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells.
Cappabianca L; Ruggieri M; Sebastiano M; Sbaffone M; Martelli I; Ruggeri P; Di Padova M; Farina AR; Mackay AR
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791513
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells.
Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
[TBL] [Abstract][Full Text] [Related]
14. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
15. A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression.
Sbaffone M; Jaffrain-Rea ML; Cappabianca L; Carbonara F; Gianno F; Feola T; Ruggieri M; Zelli V; Maccarone R; Guadagni S; Clementi M; Arcella A; Esposito V; Carozza G; Martelli I; Farina AR; Mackay AR
Biology (Basel); 2024 Mar; 13(3):. PubMed ID: 38534441
[TBL] [Abstract][Full Text] [Related]
16. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.
Bhaskara VK; Mohanam I; Rao JS; Mohanam S
PLoS One; 2012; 7(2):e30905. PubMed ID: 22363512
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
18. TrkA signal transduction pathways in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Chou TT; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):108-10. PubMed ID: 11464858
[TBL] [Abstract][Full Text] [Related]
19. Neural crest development and neuroblastoma: the genetic and biological link.
Nakagawara A
Prog Brain Res; 2004; 146():233-42. PubMed ID: 14699967
[TBL] [Abstract][Full Text] [Related]
20. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation.
Peterson S; Bogenmann E
Oncogene; 2004 Jan; 23(1):213-25. PubMed ID: 14712226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
